Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definition
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 360o synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising cancer incidences
3.2.1.2 Advancements in diagnostic technologies
3.2.1.3 Growing awareness and demand
3.2.1.4 Increased healthcare expenditures and investments
3.2.2 Industry pitfalls & challenges
3.2.2.1 High capital requirements
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
3.6 Reimbursement scenario
3.7 Future market trends
3.8 Gap analysis
3.9 Porter’s analysis
3.10 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Type, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Genetic testing
5.2.1 Next-generation sequencing (NGS)
5.2.2 Fluorescence in situ hybridization (FISH)
5.2.3 Polymerase chain reaction (PCR)
5.2.4 In situ hybridization (ISH)
5.3 Conventional testing
Chapter 6 Market Estimates and Forecast, By Application, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Breast cancer
6.3 Lung cancer
6.4 Prostate cancer
6.5 Colorectal cancer
6.6 Melanoma
6.7 Other applications
Chapter 7 Market Estimates and Forecast, By End Use, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Hospitals
7.3 Diagnostic laboratories
7.4 Cancer research institutes
7.5 Other end use
Chapter 8 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Netherlands
8.3.7 Rest of Europe
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.5.4 Rest of Latin America
8.6 Middle East and Africa
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Rest of Middle East and Africa
Chapter 9 Company Profiles
9.1 Abbott
9.2 Agilent Technologies, Inc.
9.3 Caris Life Sciences
9.4 F. Hoffmann-La Roche Ltd
9.5 Foundation Medicine, Inc.
9.6 Guardant Health
9.7 Hologic, Inc.
9.8 Illumina, Inc.
9.9 MedGenome
9.10 Myriad Genetics, Inc.
9.11 NeoGenomics Laboratories
9.12 QIAGEN
9.13 Quest Diagnostics Incorporated
9.14 SOPHiA GENETICS
9.15 Thermo Fisher Scientific, Inc.
